New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2016 Results

CRANBURY, N.J., May 12, 2016 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2016 operating results on Tuesday, May 17, 2016  before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 17, 2016 at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Webcast

Q3 Fiscal Year 2016 Financial Results Press Release

5/17/2016 at 7:30 a.m. ET



Q3 Fiscal Year 2016 Conference Call-Live

5/17/2016 at 11:00 a.m. ET

Domestic Dial-In Number

1-800-524-8850

International Dial-In Number

1-416-204-9702

Passcode

9763497



Q3 Fiscal Year 2016 Conference Call-Replay

5/17/2016-5/24/2016

Domestic Dial-In Number

1-888-203-1112

International Dial-In Number

1-719-457-0820

Passcode

9763497



Webcast Live and Replay Access

http://www.palatin.com

The webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

SOURCE Palatin Technologies, Inc.

Related Links

http://www.palatin.com

Scroll to Top